跨境ETF“百亿俱乐部”再扩容 广发基金独占五席

Group 1 - The cross-border ETF market has seen significant inflows, with over 13.8 billion yuan in net purchases since the beginning of the year, bringing the total market size to nearly 978.8 billion yuan, approaching the 1 trillion yuan mark [1] - There are currently 25 cross-border ETF products with a scale exceeding 10 billion yuan, highlighting the growing interest in this investment category [1] - GF Fund has a leading position in the cross-border ETF market, managing 11 cross-border ETFs, of which 5 have surpassed 10 billion yuan in size, accounting for 45% of the total number of such products in the market [1] Group 2 - GF Fund's flagship products include the Nasdaq ETF (159941), which has a scale exceeding 30 billion yuan and has demonstrated a strong annualized return of over 17% since its inception [2] - The Hong Kong Stock Connect Non-Bank Financial ETF (513750) is unique in tracking the non-bank financial sector in Hong Kong, with over 68% exposure to the insurance industry [2] - The Hong Kong Stock Connect Innovative Drug ETF (513120) is the largest of its kind, having increased by over 66% since 2025, showcasing the high concentration of innovative drug assets [2] Group 3 - GF Fund has been systematically developing its index business since 2008, establishing a comprehensive product line across multiple markets, including A-shares, Hong Kong stocks, US stocks, and commodities [3] - The company has received a five-star rating for its index fund management capabilities, based on a comprehensive assessment of tracking ability, excess return capability, and overall costs [3]